A Study of Ultrasound Imaging of Microscopic Blood Vessels as a Biomarker for Uterine Pathologies

Overview

About this study

The purpose of this study is to investigate the value of ultrasound imaging of microscopic blood vessels as a new biomarker for identifying the difference between benign and cancerous uterine pathologies, and to compare ultrasound imaging to the diagnostics of MRI and (if available), surgical pathology.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Confirmed uterine pathology, with a clinically indicated MRI
Age 18 or older

Exclusion Criteria

Lesions that are too small to characterize well with ultrasound
Has a positive urine pregnancy test
Adults lacking capacity to consent
Vulnerable subjects such as prisoners

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Shigao Chen, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials